Table 1 Clinical characteristics of the participants in the CAD obese and Non-CAD obese groups in the validation cohorts
CAD Obs (n = 23) | Non-CAD Obs (n = 22) | Lean control (n = 17) | |
|---|---|---|---|
Male, n(%) | 20(86.90)*£ | 11(50.00) | 5(29.40) |
Age, years | 54.10 ± 6.81 | 52.42 ± 7.40 | 55.46 ± 8.50 |
BMI(kg/m2) | 29.20 ± 2.53£ | 30.40 ± 3.40 | 21.55 ± 1.50 |
Waist(cm) | 101.50 ± 6.92£ | 103.30 ± 8.82 | 85.20 ± 6.52 |
Hip (cm) | 102.90 ± 6.72£ | 104.20 ± 7.4 | 91.50 ± 7.02 |
Waist-to-hip ratio | 0.98 ± 0.05 | 0.98 ± 0.06 | 0.94 ± 0.09 |
Hypertension, n (%) | 13(56.50) | 19(86.30) | 7(41.10) |
Diabetes, n (%) | 10(43.40)£ | 5(22.70) | 0(0.00) |
Metabolic syndrome | 12(52.17)£ | 14(60.86) | 0(0.00) |
Frequency of current smokers, n (%) | 17(73.90)*£ | 6(27.20) | 3(17.60) |
Current alcohol, n(%) | 3(13.00) | 2(9.00) | 0(0.00) |
CAD family history, n(%) | 4(17.30) | 7(31.80) | 1(5.80) |
Hyperuricemia, n(%) | 10(43.40) | 16(72.70) | 5(29.40) |
Total cholesterol(TC), mg/dL | 4.62 ± 1.24 | 4.59 ± 0.92 | 4.3 ± 1.00 |
HDL cholesterol,mg/dL | 0.95 ± 0.16 | 1.02 ± 0.18 | 1.05 ± 0.26 |
LDL cholesterol, mg/dL | 3.12 ± 1.10 | 2.83 ± 0.97 | 2.77 ± 0.87 |
Triglycerides(TG), mg/dL | 1.93 ± 0.67 | 1.78 ± 1.27 | 1.49 ± 0.64 |